Table 1.
Patient characteristics (666 patients).
|
Parameters |
No. of patients (%) |
| Treatment year | |
| 2006 to 2010 | 202 (30.3%) |
| 2011 to 2012 | 238 (35.7%) |
| 2013 to 2014 | 226 (34.0%) |
| No. of fiducial markers | |
| 3 | 25 (3.8%) |
| 4 | 638 (95.8%) |
| ≥5 | 3 (0.4%) |
| International Prostate Symptom Score | |
| Median, 7 | |
| <Median | 332 (49.8%) |
| ≥Median | 334 (50.2%) |
| Interval between prostate biopsy and fiducials | |
| <6 months | 609 (91.4%) |
| ≥6 months | 57 (8.6%) |
| Antibiotics within 6 months | 549 (82.4%) |
| Diabetes | 64 (9.6%) |
| Chronic obstructive pulmonary disease | 9 (1.4%) |
| Tamsulosin | 55 (8.3%) |
| Finesteride | 16 (2.4%) |
| Saw Palmetto | 62 (9.3%) |